• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/7

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

7 Cards in this Set

  • Front
  • Back
Type I Hyperlipidemia = hypertriglyceridemia
- recurrent bouts of pancreatitis and xanthomas
* very high plasma triglycerides
reduced or absent LPL (or apoCII)
* lack of hydrolysis of chylomicrons and VLDL

Treatment: avoid alcohol, diet supplemented with short chain fatty acids
How is Type I hyperlipidemia distinguished from familial hypertriglyceridemia?
Familial hypertriglyceridemia = Type IV characterized by hypertriglyceridemia that isn't associated with clinical signs or corneal arcus or xanthomas
* the VLDL concentration is high but the LDL and HDL remain low because this is due to a hepatic overproduction or VLDL coupled with defective clearance of VLDL
Familial Hypercholesterolemia (FH) = Type II
*caused by a mutation in the LDL-receptor - therefore see elevated LDL concentrations
*corneal arcus/ tendinous xanthomas/ xanthelasmas
* heterozygotes respond to statin drugs - homo's DO NOT
Familial type III hyperlipoproteinemia= broad beta band disease
* show tuberous xanthomas and palmar striated xanthomas
*increases in both triglycerides and cholesterol(contained within chylo remnants) & low HDL concentrations
Tangier Disease?
Characterized by:
-organe tonsils
- undetectable HDL cholesterol
- Hepatosplenomegaly
What is the common mutation in Tangier's Disease?
ABCA1 mutation
ABCA1 appears to shuttle from the late endosomal compartment to the plasma membrane = membrane bound transporter of phospholipds

*hydroxysterols regulate ABCA1 through LXR/RXR nuclear receptor pathway
* ABCA1 undergoes phosphoryalation to PKA and acts as a receptor for Apo AI
Apo B defects
<40 vs. >50 to <75
Apo B less than 40 can't make chylos = this leads to low plasma cholesterol levels and triglyceride concentrations and fat soluble vitamin deficiencies

Between 50 and 75: phenotype is high LDL because the mutation allows VLDL to be produced but interferes with the binding to the LDL-R